Tarveda: Tarveda Therapeutics to Present at Upcoming Conferences

WATERTOWN, Mass.-(BUSINESS WIRE)-Tarveda Therapeutics, Inc., a clinical stage biopharmaceutical company developing a new class of potent and selective precision oncology medicines, which it refers to as Pentarin® miniature drug conjugates, today announced that Drew Fromkin, Chief Executive Officer, will present at the LifeSci Partners Private Healthcare Company Virtual Summer Symposium, occurring August 4-5, 2020. Mr. [...]The post Tarveda Therapeutics to Present at Upcoming Conferences appeared first on Drug Genius.